Variantyx
1671 Worcester Road
Suite 300
Framingham
Massachusetts
01701
United States
Tel: 617-209-2090
Website: https://www.variantyx.com/
Email: info@variantyx.com
About Variantyx
Variantyx offers a comprehensive set of advanced Whole Genome and Whole Exome products and services for diagnostics and research use. Our product portfolio ranges from time critical rare genetic disorder diagnosis to economical large research cohort projects.YEAR FOUNDED:
2014
LEADERSHIP:
CEO: Haim Neerman
SERVICES
Please click here for Variantyx's services.
8 articles about Variantyx
-
Expanded STR Detection Capability Enables Variantyx to Diagnose Additional Genetic Disorders
11/30/2023
Variantyx, a leader in genomic precision medicine, announced that the set of short tandem repeat expansions detected by its Genomic Unity® line of whole genome-based tests has been expanded.
-
Variantyx Expands Its Reproductive Health Offerings with Launch of a Direct Replacement for Chromosomal Microarray Analysis
11/10/2023
Variantyx announced the launch of its IriSight™ CNV Analysis - a whole genome-based test for the detection of chromosomal abnormalities that correlate with clinical symptoms manifested in a fetus or a pregnancy, that may result in a genetic disorder or pregnancy loss.
-
Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding
2/14/2022
Variantyx, a technology-driven precision medicine company providing advanced genomic testing for the rare genetic disorders, reproductive health, and precision oncology markets, announced they have secured $41.5M in funding.
-
Variantyx Features Its Whole Genome Sequencing (WGS)-Based Epilepsy Test at American Epilepsy Society Annual Meeting
12/6/2019
Variantyx announced today that it will be presenting its Genomic Unity® Epilepsy Analysis testing program at the American Epilepsy Society (AES) annual meeting December 7-9 in Baltimore, Maryland.
-
Variantyx Launches Its RareDx Program, Providing Clinical Whole Genome Testing to Enrolled Patients
2/28/2019
The program is additionally expected to raise awareness of the struggles that rare disease patients face in obtaining a diagnosis and the role that clinical whole genome testing can play in ending years’ long diagnostic odysseys.
-
Variantyx Launches Variantyx Unity, The All-In-One Genomic Diagnostic Test
9/13/2017
-
Variantyx And FDNA Announce Integration Of Their Applications To Facilitate Rare Disease Diagnosis
8/30/2017
-
Variantyx Launches Genomic Intelligence Clinical Diagnostic Platform
3/21/2017